Publicaciones en las que colabora con Alberto Malvar Pintos (2)
2024
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases